Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.
about
Postoperative tamoxifen for ductal carcinoma in situPost-operative radiotherapy for ductal carcinoma in situ of the breastPost-operative radiotherapy for ductal carcinoma in situ of the breastCurrent view on ductal carcinoma in situ and importance of the margin thresholds: A reviewIntraoperative Electron Radiotherapy (IOERT) as an Alternative to Standard Whole Breast Irradiation: Only for Low-Risk Subgroups?Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In SituDuctal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomesDuctal carcinoma in situ of the breast: a surgical perspective.Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.Breast cancer (non-metastatic)Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situA new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trialTreatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.Radiotherapy in the management of early breast cancer.Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008.RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.Biological Markers Predictive of Invasive Recurrence in DCIS.Radiation therapy for ductal carcinoma in situ: a decision analysisCorrelates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.Molecular profiling of breast cancer: clinical implicationsBreast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.Role of the radiotherapy boost on local control in ductal carcinoma in situAdjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.Clinical outcomes of ductal carcinoma in situ of the breast treated with partial mastectomy without adjuvant radiotherapyDuctal Carcinoma in Situ: Clinical PerspectiveChromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancerCharacterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.A review of current practices in breast conservation surgery in the UK.Ductal carcinoma in situ: what can we learn from clinical trials?
P2860
Q24198028-790AA069-91C9-4058-BD96-54FC1E1AF45BQ24202386-248B364A-F98B-42AB-802E-E6376AA9D0BCQ24240332-33714D03-48E9-41C4-BB64-D57537E739BCQ26853548-614EB4AC-9DEE-4B7C-BD47-1119B5E48816Q26864258-ADBF8010-B906-4720-B9F3-B6152D5F30CBQ28075837-444B9AC1-90EC-4E58-BDA6-4862894D5FAEQ28270358-E63147E9-C9BF-4852-B1C6-6FCA24E9B608Q30463534-7C517307-F4B3-43CC-B629-214B6881D8E9Q30491311-5FFAE767-EE8E-4874-9813-B471E76C1EDCQ33293401-0103927E-8D2B-4263-8740-89FBC0319AC8Q33446778-7AB78F41-1ED8-47D0-9E63-32965331B2B4Q33627178-A2865AB6-583E-4296-ACCA-C778B8E7B054Q33718852-7DD04C1E-F475-4338-BE1B-5BAB629148FDQ33816606-CBF9A2E7-ED4E-4E84-A196-4D0591894398Q33924710-1C5C4A66-9B3E-4423-AEA1-6E1A1102AE1AQ34000255-8D52A70B-AAB4-4A8D-A517-FE64DB4872C9Q34038325-FF55DEE6-B05C-42D6-A832-1E0C6A0AE701Q34154192-09DB00F2-5D0B-4B76-BC92-6B7B385D2243Q34247346-751BD65D-96C1-4B40-822D-FBCB3DE715F3Q34478845-92203FD2-9202-472B-8E95-96128A825F73Q34498792-453F0A5F-E6D7-4DF3-95E4-EF5B4EC8C15AQ35023352-B4C3C1A5-BE6E-45CA-A621-7A5E6D8B7856Q35053869-4BE75716-E1E9-4811-A6E2-07B2A7C778AEQ35102484-F91E1E27-CAF1-4511-9859-FACF859676ABQ35168174-73E71A6A-B84A-4658-916D-D40911966CF1Q35181071-15B5878C-3893-4DDE-B7DC-EF7228A90F44Q35293322-47FA4AD2-1AAE-4C4E-A0D8-2E9703D8659DQ35582210-5EDFB84F-A68F-4B0A-9EA5-F51F48B54D15Q35623350-B79F1A98-0ACF-4DC2-931A-032CDBB54248Q35693856-A724C325-18F0-4F5C-A54D-0EF04383101FQ35812120-DE60969B-4608-4BA0-BC19-E57067743AC3Q35832311-D19ADF45-8750-4AC5-97FC-026B108F1429Q35904098-525DE9E9-0977-4ACA-B604-06D7ACCE453CQ35925244-DE381395-B04C-470E-9669-DBED1288551FQ35932105-CD7730EF-11C3-458F-8FED-0349139BCFB5Q35940080-109AECC1-A529-4082-8AFF-E6CC465A6374Q35945945-A85B6CAC-7C52-4B84-A185-4594A3EECA01Q35963338-57ED9F2F-F810-448C-8B93-9683A259A420Q35971024-D254D9B5-C3D0-4E61-8093-A701B819D3E9Q35977573-251F9C81-CC37-411A-9447-F3DBE9181898
P2860
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Radiotherapy and tamoxifen in ...... : randomised controlled trial.
@en
Radiotherapy and tamoxifen in ...... : randomised controlled trial.
@nl
type
label
Radiotherapy and tamoxifen in ...... : randomised controlled trial.
@en
Radiotherapy and tamoxifen in ...... : randomised controlled trial.
@nl
prefLabel
Radiotherapy and tamoxifen in ...... : randomised controlled trial.
@en
Radiotherapy and tamoxifen in ...... : randomised controlled trial.
@nl
P2093
P921
P1433
P1476
Radiotherapy and tamoxifen in ...... : randomised controlled trial.
@en
P2093
DCIS trialists in the UK, Australia, and New Zealand
Ductal Carcinoma in situ Working Party
Ian S Fentiman
Jack Cuzick
Joan Houghton
Margaret Spittle
UK Coordinating Committee on Cancer Research
W D George
P304
P356
10.1016/S0140-6736(03)13859-7
P407
P577
2003-07-01T00:00:00Z